| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 60% | 9/15 |
| Female | 40% | 6/15 |
| Indifferent | 0% | 0/15 |
| Unknown | 0% | 0/15 |
| General | ||
| Birth Length | 0% | 0/15 |
| 6.7% | 1/15 | |
| Birth Head circumference | 0% | 0/15 |
| 6.7% | 1/15 | |
| 6.7% | 1/15 | |
| 6.7% | 1/15 | |
| 93.3% | 14/15 | |
| 100% | 15/15 | |
| 93.3% | 14/15 | |
| 92.9% | 13/14 | |
| Neurology | ||
| 26.7% | 4/15 | |
| 46.7% | 7/15 | |
| 20% | 3/15 | |
| Facial abnormalities | ||
| 20% | 3/15 | |
| 53.3% | 8/15 | |
| 53.3% | 8/15 | |
| 73.3% | 11/15 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/15 |
| Abnormal vision | 0% | 0/15 |
| Heart | ||
| 13.3% | 2/15 | |
| Pulmonary | ||
| 6.7% | 1/15 | |
| Gastrointestinal | ||
| Gastrointestinal | 0% | 0/15 |
| Urogenital | ||
| 13.3% | 2/15 | |
| Skeleton | ||
| 46.7% | 7/15 | |
| Skin / Hair / Nails | ||
| 20% | 3/15 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/15 |
| Metabolic | 0% | 0/15 |
| Immune | 0% | 0/15 |
| Neoplasia | ||
| Neoplasia | 0% | 0/15 |
| Inheritance | ||
| 100% | 15/15 | |
METTL23